1. Home
  2. PHGE vs LUCY Comparison

PHGE vs LUCY Comparison

Compare PHGE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • LUCY
  • Stock Information
  • Founded
  • PHGE 2015
  • LUCY 2017
  • Country
  • PHGE Israel
  • LUCY United States
  • Employees
  • PHGE N/A
  • LUCY N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • LUCY Ophthalmic Goods
  • Sector
  • PHGE Health Care
  • LUCY Health Care
  • Exchange
  • PHGE Nasdaq
  • LUCY Nasdaq
  • Market Cap
  • PHGE 13.3M
  • LUCY 14.5M
  • IPO Year
  • PHGE N/A
  • LUCY 2022
  • Fundamental
  • Price
  • PHGE $0.96
  • LUCY $4.55
  • Analyst Decision
  • PHGE Strong Buy
  • LUCY Strong Buy
  • Analyst Count
  • PHGE 2
  • LUCY 1
  • Target Price
  • PHGE $13.50
  • LUCY $20.00
  • AVG Volume (30 Days)
  • PHGE 48.8K
  • LUCY 22.7K
  • Earning Date
  • PHGE 04-02-2025
  • LUCY 03-24-2025
  • Dividend Yield
  • PHGE N/A
  • LUCY N/A
  • EPS Growth
  • PHGE N/A
  • LUCY N/A
  • EPS
  • PHGE N/A
  • LUCY N/A
  • Revenue
  • PHGE N/A
  • LUCY $1,561,506.00
  • Revenue This Year
  • PHGE N/A
  • LUCY $68.16
  • Revenue Next Year
  • PHGE N/A
  • LUCY $636.84
  • P/E Ratio
  • PHGE N/A
  • LUCY N/A
  • Revenue Growth
  • PHGE N/A
  • LUCY 158.62
  • 52 Week Low
  • PHGE $0.48
  • LUCY $3.26
  • 52 Week High
  • PHGE $8.55
  • LUCY $27.20
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 65.22
  • LUCY 39.25
  • Support Level
  • PHGE $0.87
  • LUCY $4.83
  • Resistance Level
  • PHGE $0.99
  • LUCY $4.95
  • Average True Range (ATR)
  • PHGE 0.08
  • LUCY 0.34
  • MACD
  • PHGE 0.01
  • LUCY -0.03
  • Stochastic Oscillator
  • PHGE 89.20
  • LUCY 27.27

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

Share on Social Networks: